TABARRINI, Oriana
 Distribuzione geografica
Continente #
AS - Asia 7.365
NA - Nord America 6.820
EU - Europa 5.123
SA - Sud America 740
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 20.184
Nazione #
US - Stati Uniti d'America 6.689
CN - Cina 2.863
SG - Singapore 2.237
IT - Italia 912
VN - Vietnam 792
IE - Irlanda 769
UA - Ucraina 699
RU - Federazione Russa 668
HK - Hong Kong 644
SE - Svezia 594
BR - Brasile 575
DE - Germania 351
FI - Finlandia 246
FR - Francia 234
GB - Regno Unito 178
KR - Corea 178
IN - India 116
BE - Belgio 106
TR - Turchia 88
PL - Polonia 83
BD - Bangladesh 71
AR - Argentina 59
CA - Canada 59
JP - Giappone 56
IQ - Iraq 52
AT - Austria 51
MX - Messico 50
RO - Romania 45
NL - Olanda 44
PK - Pakistan 39
UZ - Uzbekistan 36
ES - Italia 34
SA - Arabia Saudita 34
ID - Indonesia 29
ZA - Sudafrica 29
CH - Svizzera 28
EC - Ecuador 25
CZ - Repubblica Ceca 23
PH - Filippine 20
VE - Venezuela 18
CI - Costa d'Avorio 17
CO - Colombia 17
CL - Cile 16
EG - Egitto 15
AE - Emirati Arabi Uniti 13
MA - Marocco 13
ET - Etiopia 12
KE - Kenya 12
PY - Paraguay 12
JO - Giordania 11
LB - Libano 10
MY - Malesia 10
GR - Grecia 8
IL - Israele 8
IR - Iran 8
LT - Lituania 8
LV - Lettonia 8
TN - Tunisia 8
UY - Uruguay 7
PA - Panama 6
PE - Perù 6
KG - Kirghizistan 5
NP - Nepal 5
AL - Albania 4
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
HR - Croazia 3
JM - Giamaica 3
LK - Sri Lanka 3
LY - Libia 3
OM - Oman 3
RS - Serbia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 20.162
Città #
Guangzhou 2.083
Singapore 1.656
Chandler 1.002
Dublin 769
Hong Kong 628
San Jose 580
Perugia 514
Dong Ket 503
San Mateo 414
Ashburn 395
Jacksonville 358
Boardman 278
Santa Clara 249
Beijing 192
Moscow 185
Medford 177
Princeton 176
Seoul 174
Lauterbourg 162
Ann Arbor 146
Wilmington 134
Altamura 125
Los Angeles 120
The Dalles 116
Lawrence 111
Ho Chi Minh City 110
Brussels 106
Munich 104
Andover 95
New York 89
Piscataway 76
Fremont 66
São Paulo 65
Hanoi 60
West Jordan 58
Warsaw 53
Tokyo 51
Des Moines 50
Helsinki 47
Saint Petersburg 47
Orem 46
Turku 46
Redmond 43
Nanjing 40
Dallas 35
Norwalk 34
Vienna 34
Brooklyn 33
Atlanta 32
Council Bluffs 32
Woodbridge 31
Izmir 30
Chennai 28
Bucharest 26
Chicago 26
Baghdad 25
Denver 25
Hefei 25
Dhaka 24
Montreal 24
Rio de Janeiro 22
San Paolo di Civitate 21
Dearborn 20
Tashkent 20
Ankara 19
London 19
Phoenix 19
Poplar 19
Redwood City 19
Rome 19
Shanghai 19
Falls Church 18
Houston 18
Johannesburg 18
Stockholm 18
Abidjan 17
Da Nang 17
Columbus 16
Spoleto 16
Buffalo 15
Mexico City 15
San Diego 15
Secaucus 15
Nuremberg 14
Philadelphia 14
Porto Alegre 14
Toronto 14
Barnet 13
Chongqing 13
Lahore 13
Mumbai 13
Riyadh 13
Seattle 13
Belo Horizonte 12
Haiphong 12
Hanover 12
Manchester 12
Milan 12
Addis Ababa 11
Amsterdam 11
Totale 13.593
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.139
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 332
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 328
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 317
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 314
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 249
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 200
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 181
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 160
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 154
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 154
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 142
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 141
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 140
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 139
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 138
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 138
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 137
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 136
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 135
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 133
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 133
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 132
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 132
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 132
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 129
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 128
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 127
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
6-Aminoquinolones as New Potential Anti-HIV Agents 125
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 125
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 124
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 124
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 122
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 122
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 121
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 120
6-Desfluoroquinolones as promising HIV transcription inhibitors 119
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 119
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 118
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 116
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 115
S. aureus NorA efflux pump: the discovery of new potent inhibitors 115
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 115
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 115
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 114
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 112
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 112
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 112
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 111
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 111
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 110
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 110
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 110
A New Derivative with Ultra-Potent Anti-HIV Activity 109
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 109
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 109
6-Hydroxy Derivative as New Desfluoroquinolone (DFQ): Synthesis and DNA-binding Study 108
A new 6-aminoquinolone compound with anti-HCMV activity 107
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 107
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 107
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 105
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 104
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 104
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 103
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 103
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 103
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors. 101
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 101
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 101
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 101
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 100
QSAR study and VolSurf characterization of anti-HIV quinolone library 99
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 98
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 98
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 97
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 97
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 96
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 96
Antiviral 6-aminoquinolones: Molecolar basis for potency and selectivity. 95
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 95
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 94
In Vitro Activities of New Quinolones Against Helicobacter pylori 93
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 93
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 92
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 92
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 92
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 90
New compounds targeting the rna polymerase of influenza a and b viruses. 90
Nuovi Tiopiranopiridinil Chinoloni 89
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 89
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs 88
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 87
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 86
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 86
Structure modifications of 6-aminoquinolones with potent anti-HIV activity 86
Totale 14.403
Categoria #
all - tutte 77.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021706 0 0 0 0 0 0 0 0 0 65 109 532
2021/20221.733 52 301 36 112 116 11 32 488 89 51 211 234
2022/20232.873 199 482 37 268 266 304 3 171 1.001 21 87 34
2023/20243.324 69 191 67 30 20 29 2.333 28 137 88 148 184
2024/20253.157 35 270 115 261 367 163 292 182 544 196 483 249
2025/20266.026 426 446 322 834 835 596 1.054 366 708 439 0 0
Totale 20.732